PPARs: Protectors or Opponents of Myocardial Function?
نویسندگان
چکیده
منابع مشابه
PPARs: Protectors or Opponents of Myocardial Function?
Over 5 million people in the United States suffer from the complications of heart failure (HF), which is a rapidly expanding health complication. Disorders that contribute to HF include ischemic cardiac disease, cardiomyopathies, and hypertension. Peroxisome proliferator-activated receptors (PPARs) are members of the nuclear receptor family. There are three PPAR isoforms: PPARα, PPARγ, and PPAR...
متن کاملProtectors or Perpetrators
To The Editor: World Health Day is celebrated globally every year on 7 April, to mark the Anniversary of the 1948 founding of the World Health Organization (WHO). The aim of celebrating this day every year is to raise awareness on a key global health issue. The theme of World Health Day 2009 is – "Save lives. Make hospitals safe in emergencies", which focuses on the importance of investing in h...
متن کاملExpression and Function of PPARs in Placenta
Peroxisome proliferator-activated receptors (PPAR) are members of the superfamily of nuclear hormone receptors involved in embryonic development and differentiation of several tissues including placenta, which respond to specific ligands such as polyunsaturated fatty acids by altering gene expression. Three subtypes of this receptor have been discovered, each evolving to achieve different biolo...
متن کاملPhytoestrogens and breast cancer--promoters or protectors?
The majority of breast cancers are oestrogen dependent and in postmenopausal women the supply of oestrogens in breast tissue is derived from the peripheral conversion of circulating androgens. There is, however, a paradox concerning the epidemiology of breast cancer and the dietary intake of phytoestrogens that bind weakly to oestrogen receptors and initiate oestrogen-dependent transcription. I...
متن کاملStatins: protectors or pretenders in prostate cancer?
The role of statin therapy in prostate cancer (PCa) prevention and treatment is plagued by controversy. This critical review of published clinical series reveals several caveats in earlier studies, which reported no benefit. Recent studies that adjust for confounding factors have demonstrated statin therapy to be associated with PCa prevention and favorable clinical outcomes. Developed as inhib...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: PPAR Research
سال: 2015
ISSN: 1687-4757,1687-4765
DOI: 10.1155/2015/835985